Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice.
Ontology highlight
ABSTRACT: In humans, loss-of-function mutations in the UBE3A gene lead to the neurodevelopmental disorder Angelman syndrome (AS). AS patients have severe impairments in speech, learning and memory, and motor coordination, for which there is currently no treatment. In addition, UBE3A is duplicated in > 1-2% of patients with autism spectrum disorders-a further indication of the significant role it plays in brain development. Altered expression of UBE3A, an E3 ubiquitin ligase, is hypothesized to lead to impaired levels of its target proteins, but identifying the contribution of individual UBE3A targets to UBE3A-dependent deficits remains of critical importance. Ephexin5 is a putative UBE3A substrate that has restricted expression early in development, regulates synapse formation during hippocampal dev
SUBMITTER: Sell GL
PROVIDER: S-EPMC8484563 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA